T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine

International Journal of Infectious Diseases

Volumn 27, Issue , 2014, Pages 37-43

  Li, Junwei ^a   Arévalo, Maria T ^a   Chen, Yanping ^a   Chen, Shan ^a   Zeng, Mingtao ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Cross strain protective immunity; Heterologous influenza viruses; Live attenuated influenza vaccine; Prime boost vaccination; T cell mediated immunity; Trivalent inactivated influenza vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; INACTIVATED VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PROTECTION; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HONG KONG INFLUENZA; HUMORAL IMMUNITY; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; LUNG FLUID; MOUSE; NONHUMAN; SURVIVAL RATE; T CELL DEPLETION; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHICK EMBRYO; CROSS REACTION; DOG; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; MDCK CELL LINE; ORTHOMYXOVIRIDAE INFECTIONS; RANDOMIZATION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CHICK EMBRYO; CROSS REACTIONS; DOGS; IMMUNIZATION, SECONDARY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RANDOM ALLOCATION; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 84907244742     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.05.016     Document Type: Article

References (50)

1. Li J., Arevalo M.T., Zeng M. Engineering influenza viral vectors. Bioengineered 2013, 4:9-14.
2. Horimoto T., Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005, 3:591-600.
3. Wise H.M., Foeglein A., Sun J., Dalton R.M., Patel S., Howard W., et al. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 2009, 83:8021-8031.
4. Jagger B.W., Wise H.M., Kash J.C., Walters K.A., Wills N.M., Xiao Y.L., et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337:199-204.
5. Tong S., Li Y., Rivailler P., Conrardy C., Castillo D.A., Chen L.M., et al. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 2012, 109:4269-4274.
6. Reid A.H., Taubenberger J.K., Fanning T.G. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol 2004, 2:909-914.
7. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Infect Dis 2006, 12:9-14.
8. Vallat B. Flu: no sign so far that the human pandemic is spread by pigs. Nature 2009, 460:683.
9. Medina R.A., Garcia-Sastre A. Influenza A viruses: new research developments. Nat Rev Microbiol 2011, 9:590-603.
10. Abelin A., Colegate T., Gardner S., Hehme N., Palache A. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective. Vaccine 2011, 29:1135-1138.
11. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
12. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
13. Vaillant L., La Ruche G., Tarantola A., Barboza P. epidemic intelligence team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009, 14. pii:19366.
14. Kelly H., Grant K., Williams S., Smith D. H1N1 swine origin influenza infection in the United States and Europe in 2009 may be similar to H1N1 seasonal influenza infection in two Australian states in 2007 and 2008. Influenza Other Respir Viruses 2009, 3:183-188.
15. Nolan T., McVernon J., Skeljo M., Richmond P., Wadia U., Lambert S., et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303:37-46.
16. Chen G.L., Lau Y.F., Lamirande E.W., McCall A.W., Subbarao K. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci U S A 2011, 108:1140-1145.
17. AVMA guidelines for the euthanasia of animals: 2013 edition. Schaumburg, IL: AVMA; 2013, p. 1-102.
18. Xu Q., Pichichero M.E., Simpson L.L., Elias M., Smith L.A., Zeng M. An adenoviral vector-based mucosal vaccine is effective in protection against botulism. Gene Therapy 2009, 16:367-375.
19. Kaur R., Chen S., Arevalo M.T., Xu Q., Chen Y., Zeng M. Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis. Clin Vaccine Immunol 2012, 19:359-364.
20. Grund S., Adams O., Wahlisch S., Schweiger B. Comparison of hemagglutination inhibition assay, an ELISA-based microneutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J Virol Methods 2011, 171:369-373.
21. Qu M., Li J., Jia L., Tan X.J., Gao Z.Y., Yan H.Q., et al. [Etiology of hand-foot-and-mouth disease and genetic characteristics of coxsackievirus A16 in Beijing, 2009]. Bing Du Xue Bao 2010, 26:432-436.
22. Wang W., Anderson C.M., De Feo C.J., Zhuang M., Yang H., Vassell R., et al. Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog 2011, 7:e1002081.
23. Fiers W., De Filette M., Birkett A., Neirynck S., Min Jou W. A “universal“ human influenza A vaccine. Virus Res 2004, 103:173-176.
24. De Filette M., Martens W., Roose K., Deroo T., Vervalle F., Bentahir M., et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem 2008, 283:11382-11387.
25. Manicassamy B., Medina R.A., Hai R., Tsibane T., Stertz S., Nistal-Villan E., et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 2010, 6:e1000745.
26. Tang F.Y., Zu R.Q., Li L., Qi X., Ji H., Wu B., et al. [Serologic survey on pandemic influenza A (H1N1) virus among aged >/= 3 years population from Jiangsu Province in 2009, China]. Zhonghua Liu Xing Bing Xue Za Zhi 2010, 31:489-493.
27. Medina R.A., Rojas M., Tuin A., Huff S., Ferres M., Martinez-Valdebenito C., et al. Development and characterization of a highly specific and sensitive SYBR green reverse transcriptase PCR assay for detection of the 2009 pandemic H1N1 influenza virus on the basis of sequence signatures. J Clin Microbiol 2011, 49:335-344.
28. Medina R.A., Manicassamy B., Stertz S., Seibert C.W., Hai R., Belshe R.B., et al. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun 2010, 1:28.
29. Gras S., Kedzierski L., Valkenburg S.A., Laurie K., Liu Y.C., Denholm J.T., et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A 2010, 107:12599-12604.
30. Pearce M.B., Belser J.A., Gustin K.M., Pappas C., Houser K.V., Sun X., et al. Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus in ferrets. J Virol 2012, 86(13):7118-7125.
31. Tu W., Mao H., Zheng J., Liu Y., Chiu S.S., Qin G., Cytotoxic T., et al. lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010, 84:6527-6535.
32. Fang Y., Banner D., Kelvin A.A., Huang S.S., Paige C.J., Corfe S.A., et al. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J Virol 2012, 86:2229-2238.
33. Sun K., Ye J., Perez D.R., Metzger D.W. Seasonal FluMist vaccination induces cross-reactive T-cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol 2011, 186:987-993.
34. Bodewes R., Kreijtz J.H., Geelhoed-Mieras M.M., van Amerongen G., Verburgh R.J., van Trierum S.E., et al. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 2011, 85:2695-2702.
35. Hillaire M.L., van Trierum S.E., Kreijtz J.H., Bodewes R., Geelhoed-Mieras M.M., Nieuwkoop N.J., et al. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. J Gen Virol 2011, 92:2339-2349.
36. Guo H., Santiago F., Lambert K., Takimoto T., Topham D.J. T-cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol 2011, 85:448-455.
37. Skountzou I., Koutsonanos D.G., Kim J.H., Powers R., Satyabhama L., Masseoud F., et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010, 185:1642-1649.
38. Topham D.J., Tripp R.A., Doherty P.C. CD8+ T-cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997, 159:5197-5200.
39. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006, 12:48-54.
40. Brown D.M., Dilzer A.M., Meents D.L., Swain S.L. CD4 T-cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 2006, 177:2888-2898.
41. Topham D.J., Tripp R.A., Sarawar S.R., Sangster M.Y., Doherty P.C. Immune CD4+ T-cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium. J Virol 1996, 70:1288-1291.
42. Crowe S.R., Miller S.C., Brown D.M., Adams P.S., Dutton R.W., Harmsen A.G., et al. Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 2006, 24:457-467.
43. Babon J.A., Cruz J., Ennis F.A., Yin L., Terajima M. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus. J Virol 2012, 86:9233-9243.
44. Duvvuri V.R., Marchand-Austin A., Eshaghi A., Patel S.N., Low D.E., Gubbay J.B. Potential T-cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study. Vaccine 2012, 30:6054-6063.
45. McKinstry K.K., Strutt T.M., Kuang Y., Brown D.M., Sell S., Dutton R.W., et al. Memory CD4+ T-cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 2012, 122:2847-2856.
46. Wilkinson T.M., Li C.K., Chui C.S., Huang A.K., Perkins M., Liebner J.C., et al. Preexisting influenza-specific CD4+ T-cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18:274-280.
47. Schmidt T., Dirks J., Enders M., Gartner B.C., Uhlmann-Schiffler H., Sester U., et al. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Eur J Immunol 2012, 42:1755-1766.
48. Weinfurter J.T., Brunner K., Capuano S.V., Li C., Broman K.W., Kawaoka Y., et al. Cross-reactive T-cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS pathogens 2011, 7:e1002381.
49. Ge X., Tan V., Bollyky P.L., Standifer N.E., James E.A., Kwok W.W. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010, 84:3312-3319.
50. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011, 204:845-853.